Bio-Rad launches PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers
HERCULES, Calif. — Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announces the launch of its PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers, designed to support PCR applications in basic and translational research, process development, and quality control.
Fundraising extension to >£20m for Eagle Genomics and appointment of new leadership
Eagle Genomics is pleased to announce it has raised additional financing of £3 million (USD $4 million) to further deploy its pioneering software platform that enables corporate customers to explore and monetize on microbiome-related research. The current funding brings Eagle’s total capital raising to over £20 million (USD $25 million) over the last 12 months. Together with this fundraising, the…
What makes a good question bank?
A good question bank provides the flexibility to customise assessments according to institutional needs. For example, by learning objectives, curriculum areas or difficulty.
Portsmouth Aviation and 42 Technology collaborate to bring Exovent ventilator to market
UK manufacturer Portsmouth Aviation has appointed 42 Technology (42T) as a strategic development partner to help bring its unique Exovent negative pressure ventilator (NPV) system to market.
Genetic code of rare kidney cancer cracked
The genetic code of a rare form of kidney cancer, called reninoma, has been studied for the first time.
Revvity expands access to base editing technology with aim to accelerate discovery to cure
Launch of Pin-pointTM base editing reagents improves access to new-generation editing technology Access to the Pin-point system now bridges discovery, preclinical and clinical with the same technology platform Reagent launch puts clinica
Evonetix unveils new branding to align with its vision for gene-length DNA synthesis
Reflects evolution of the Company from research and development towards scale-up and commercialization
Start Codon invites life sciences leaders, founders and investors to Innovation Showcase 2023
Cambridge, UK - Start Codon, a life science and healthcare venture-building fund, is pleased to invite life sciences leaders, entrepreneurs, and investors from across the life science and biotech industries to attend their Innovation Showcase 2023.
CUH celebrates reaccreditation as a Veteran Aware hospital
Cambridge University Hospitals NHS Foundation Trust celebrated its commitment to military families at a recent special event.
Region gets first bone marrow transplant service for young
Addenbrooke’s Hospital is to get the region’s first paediatric bone marrow transplant service, saving lives and avoiding gruelling journeys to specialist centres hundreds of miles away.
PetMedix joins Zoetis to bring the benefits of species-specific antibody therapies to pet owners
PetMedix, a leader in discovering species-specific therapeutic antibodies for pets, announced that it has been acquired by Zoetis, the world’s leading animal health company. Both parties have collaborated since 2022 with respect to antibody discovery.
CMR Surgical surpasses 15,000 surgical procedures on Versius globally as it raises $165 million to support continued growth
CMR Surgical, the global surgical robotics business, announces that its next-generation Versius® Surgical Robotic System has been used to perform more than 15,000 surgeries globally. The surgical cases span more than 130 complex and benign procedure types including colectomies, hernia repairs, hysterectomies, sacrocolpopexies, and lobectomies across seven surgical specialties.
Xampla launches consumer brand – Morro – as public says plastic is ‘material of the past’
Cambridge-based Xampla, reveals its first ever consumer brand – Morro.
Optibrium releases powerful metabolism prediction capability in next generation StarDrop software
Cambridge, UK – Optibrium, a leading developer of software and AI solutions for drug discovery, launches the latest version of its drug discovery platform, StarDrop 7.5, introducing a powerful module for drug metabolism prediction.
Get to know the inflammatory bowel disease (IBD) team at the NIHR BioResource
Who are they, what a day looks like in the team and everything involved in making our Inflammatory Bowel Disease (IBD) team one of the core cogs in the workings of the NIHR BioResource!
Ion channel drug developer Maxion Therapeutics appoints Eva-Lotta Allan as Chair of its Board of Directors
Maxion Therapeutics (“Maxion”), the biotechnology company developing antibody-based drugs for previously untreatable ion channel- and GPCR-driven diseases, announced the appointment of senior industry leader Eva-Lotta Allan as the Chair of its Board of Directors. The announcement comes at an important moment of growth by the company as it advances its lead programme towards the clinic, following…
Reflecting on our campaign to increase volunteer diversity
NIHR BioResource for Translational Research writes...As our 12-week campaign with Egality Health and eight community-based health advocacy organisations has come to a close, we’re reflecting on our successes and sharing some key learnings going forward. We also heard from some of our community organisation leaders on their thoughts on the campaign and the future of health research.
Optical Genome Mapping shines light on complex structural variants in Genome
Unlock a 25% discount today on all OGM services with Source Genomics, limited time only.
SPT Labtech Empowers UK Genomics Community by Opening its Doors for the firefly® Roadshow
Cambridge, UK, 19 September 2023 – SPT Labtech, a global leader in the design and development of automated instrumentation and consumables for life science applications, will host the UK leg of the firefly®
Takeda and Sanofi join Milner Therapeutics Consortium
The Milner Therapeutics Institute are excited to announce that two new pharma partners — Takeda and Sanofi — have joined the Milner Consortium in the past month.